The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin

International Journal of Pharmaceutics

Volumn 357, Issue 1-2, 2008, Pages 126-131

  Choi, Ahyoung ^a   Gang, Hyesil ^a   Chun, Inkoo ^b   Gwak, Hyesun ^a  

^a Ewha Womans University   (South Korea)

^b Dongduk Women's University   (South Korea)

Author keywords

Alendronate; Fatty acids; Percutaneous absorption; Propylene glycol

Indexed keywords

ALENDRONIC ACID; DECANOIC ACID; FATTY ACID; LAURIC ACID; LINOLEIC ACID; OCTANOIC ACID; OLEIC ACID; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; HAIRLESS MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; FATTY ACIDS; MALE; MICE; MICE, INBRED HRS; PROPYLENE GLYCOL; SKIN ABSORPTION; SOLUBILITY; VEHICLES;

EID: 42749086215     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.01.050     Document Type: Article

References (27)

1. Ansel H.C., Popovich N.G., and Allen L.V. Pharmaceutical Dosage Forms and Drug Delivery Systems (1995), Williams & Wilkins, Malvern pp. 357-372
2. Aungst B.J., Blake J.A., and Hussain M.A. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7 (1990) 712-718
3. Aungst B.J., Rogers N.J., and Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33 (1986) 225-234
4. Barry B.W. Dermatological Formulations (1983), Marcel Dekker, New York pp. 49-94
5. Barry B.W. Mode of action of penetration enhancers in human skin. J. Control. Res. 6 (1987) 85-97
6. Bond J.R., and Barry B.W. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J. Invest. Dermatol. 90 (1988) 810-813
7. Beek E.R., Cohen L.H., Leroy I.M., Ebetino F.H., Löwik C.W.G.M., and Papapoulos S.E. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonate. Bone 33 (2003) 805-811
8. Chien Y.W., and Lambert H.J. Controlled drug release from polymeric delivery devices II: differentiation between partition-controlled and matrix-controlled drug release mechanism. J. Pharm. Sci. 63 (1974) 515-519
9. Cho Y.A., and Gwak H.S. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 30 (2004) 557-564
10. Cooper E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 73 (1984) 1153-1156
11. Cooper E.R., Merritt E.W., and Smith R.L. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 74 (1985) 688-689
12. Golden G.M., McKie J.E., and Potts R.O. Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76 (1987) 25-28
13. Green P.G., Guy R.H., and Hadgraft J. In vitro and in vivo enhancement of skin permeation with oleic acid and lauric acids. Int. J. Pharm. 48 (1988) 103-111
14. Gur A., Colpan L., Cevik R., Nas K., and Sarac A.J. Comparison of zinc excretion and biochemical markers of bone remodeling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis. Clin. Biochem. 38 (2005) 66-72
15. Gwak H.S., and Chun I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 236 (2002) 57-64
16. Hosking D., Chilvers C., Christiansen C., Ravn P., Wasnich R., Ross P., McClung M., Balske A., Thompson D., Daley M., and Yates A.J. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N. Engl. J. Med. 338 (1998) 485-492
17. Kadir R., Ponec M., Tiemessen H.L.G.M., Junginger H.E., and Boddé H.E. Oleyl surfactants as skin penetration enhancers: effects on human stratum corneum permeability and in vitro toxicity to cultured human skin cells. In: Walters K.A., and Hadgraft J. (Eds). Pharmaceutical Skin Penetration Enhancement vol. 59 (1993), Marcel Dekker, Inc., New York 215-228
18. Lacy C.F., Amstrong L.L., Goldman M.P., and Lance L.L. Drug Information Handbook (2007), Lexi-comp, Hudson pp. 63-64
19. Nomura H., Fusao K., Sugimoto Y., Miyashita Y., Dohi M., and Kato Y. Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG base) through rat skin: effects of oleic acid added to FAPG base. Chem. Pharm. Bull. 38 (1990) 1421-1424
20. Ponec M., Haverkort M., Soei Y.L., Kempenaar J., and Boddé H.E. Use of human keratinocyte and fibroblast cultures for toxicity studies of topically applied compounds. J. Pharm. Sci. 79 (1990) 312-316
21. Ponec M., Haverkort M., Soei Y.L., Kempenaar J., Brussee H., and Boddé H.E. Toxicity screening of n-alkylazacycloheptan-2-one derivatives in cultured human skin cells: structure-toxicity relationships. J. Pharm. Sci. 78 (1989) 738-741
22. Ptáček P., Klima J., and Macek J. Determination of alendronate in human urine as 9-fluorenylmethyl derivative by high-performance liquid chromatography. J. Chromatogr. B 767 (2002) 111-116
23. Raykar P.V., Fung M.C., and Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm. Res. 5 (1988) 140-150
24. Russell R., and Rogers M. Bisphosphonates: from laboratory to the clinic and back again. Bone 25 (1999) 97-106
25. Sato M., and Grasser W. Effect of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J. Bone Miner. Res. 5 (1990) 31-40
26. Schenk R., Eggi D.P., Fleisch D.P., and Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new amino-bisphosphonates on bone resorption in the rat. Calcif. Tissue Int. 38 (1986) 342-349
27. Yamada M., Uda Y., and Tanigawara Y. Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull. 35 (1987) 3399-3406